The year 2026 marks a significant milestone for the European Union’s (EU) Health Tec...
Read moreThe HTA Coordination Group (HTACG) has now confirmed the 2026 request periods for joint scientific c...
Read moreISPOR Europe 2025 brought together global HTA bodies, payers, industry leaders and patient organisat...
Read more2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...
Read moreClinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...
Read moreObjectives: EUHTA regulation has applied from the 1st January 2025 for oncology pr...
Read moreObjectives: To analyse how the mandatory EU Joint Clinical Assessment (JCA) could in...
Read moreSurrogate Endpoints in HTA Decision-Making The need to stay ahead of competitors and offset losses f...
Read moreOptimising evidence generation in trial design, while navigating regulatory and local payer requirem...
Read moreSuccessfully navigating early payer scientific advice whether through Joint Scientific Consultations...
Read more